Annals of Nuclear Medicine最新文献

筛选
英文 中文
Design, radiochemical characterization and preclinical evaluation of a 64Cu-labeled 2-methyl-8-hydroxyquinoline complex as a PET tracer. 64cu标记的2-甲基-8-羟基喹啉配合物作为PET示踪剂的设计、放射化学表征和临床前评估。
IF 2.4 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-11-13 DOI: 10.1007/s12149-026-02310-0
Masoumeh Hemmati, Yousef Fazaeli, Shahzad Feizi
{"title":"Design, radiochemical characterization and preclinical evaluation of a <sup>64</sup>Cu-labeled 2-methyl-8-hydroxyquinoline complex as a PET tracer.","authors":"Masoumeh Hemmati, Yousef Fazaeli, Shahzad Feizi","doi":"10.1007/s12149-026-02310-0","DOIUrl":"https://doi.org/10.1007/s12149-026-02310-0","url":null,"abstract":"<p><p>Direct radiolabeling of cellular therapeutics and leukocytes represents a vital strategy for monitoring inflammatory loci and tracking cell-based therapies in vivo. While single-photon emission computed tomography (SPECT) agents, such as <sup>111</sup>In-oxine and <sup>99m</sup>Tc-HMPAO, have long served as clinical mainstays, their utility is constrained by limited spatial resolution and suboptimal quantification. To address these limitations, we developed and preclinically validated <sup>64</sup>Cu-labeled 2-methyl-8-hydroxyquinoline (<sup>64</sup>Cu-HMQ) as a neutral, lipophilic positron emission tomography (PET) tracer intended for high-resolution, quantitative cell-tracking paradigms (e.g., autologous leukocytes, stem cells, and immunotherapeutic vectors). <sup>64</sup>Cu-HMQ was synthesized with high radiochemical yield (> 98%) and demonstrated robust in vitro stability in both formulation buffer and human serum over 12 h. The complex exhibited an optimal partition coefficient (logP = 1.4), providing the requisite membrane permeability for intracellular transport while maintaining adequate hydrophilicity. Baseline preclinical biodistribution and PET imaging in healthy rodents revealed favorable pharmacokinetic characteristics, marked by efficient blood and systemic clearance blood clearance, combined hepatobiliary and renal elimination, and minimal non-specific background accumulation. These foundational results establish the coordination integrity and intrinsic clearance kinetics of <sup>64</sup>Cu-HMQ, demonstrating its strong translational potential as a long-lived (T<sub>1/2</sub>=12.7 h), quantitative PET alternative to conventional <sup>111</sup>In-oxine for direct cell labeling and non-invasive PET cell tracking. In vitro leukocyte labeling confirmed high radiolabeling efficiency (71.2 ± 3.1%) with preserved cell viability (> 95%), highlighting its potential feasibility for cell-tracking applications.</p>","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149401299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Impact of biguanide therapy on hepatic 18F-fluorodeoxyglucose-positron emission tomography quantitative parameters in patients with diabetes: a dynamic positron emission tomography study. 更正:双胍治疗对糖尿病患者肝脏18f -氟脱氧葡萄糖-正电子发射断层扫描定量参数的影响:一项动态正电子发射断层扫描研究。
IF 2.4 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-11-11 DOI: 10.1007/s12149-026-02311-z
Akiko Tomiyama, Yu Iwabuchi, Kai Tonda, Yoshiki Owaki, Arashi Fujita, Ryosuke Sakurai, Atsushi Shimizu, Maho Kurihara, Togo Kogo, Yuki Iwaita, Takehiro Nakahara, Tohru Shiga, Yoshitake Yamada, Masahiro Jinzaki
{"title":"Correction: Impact of biguanide therapy on hepatic <sup>18</sup>F-fluorodeoxyglucose-positron emission tomography quantitative parameters in patients with diabetes: a dynamic positron emission tomography study.","authors":"Akiko Tomiyama, Yu Iwabuchi, Kai Tonda, Yoshiki Owaki, Arashi Fujita, Ryosuke Sakurai, Atsushi Shimizu, Maho Kurihara, Togo Kogo, Yuki Iwaita, Takehiro Nakahara, Tohru Shiga, Yoshitake Yamada, Masahiro Jinzaki","doi":"10.1007/s12149-026-02311-z","DOIUrl":"https://doi.org/10.1007/s12149-026-02311-z","url":null,"abstract":"","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149392458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deep progressive reconstruction for low-dose ¹⁸F-FDG PET/CT imaging in pediatric patients. 儿童低剂量¹⁸F-FDG PET/CT成像的深度渐进式重建。
IF 2.4 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-11-05 DOI: 10.1007/s12149-026-02305-x
Yanqiong Chen, Di Zhang, Shuming Zhang, Jiong Li, Xiaoxia Wang
{"title":"Deep progressive reconstruction for low-dose ¹⁸F-FDG PET/CT imaging in pediatric patients.","authors":"Yanqiong Chen, Di Zhang, Shuming Zhang, Jiong Li, Xiaoxia Wang","doi":"10.1007/s12149-026-02305-x","DOIUrl":"https://doi.org/10.1007/s12149-026-02305-x","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the performance of the deep progressive reconstruction method (DPR) for low-dose <sup>18</sup>F-FDG PET imaging in pediatric patients.</p><p><strong>Methods: </strong>Forty-one pediatric patients who underwent clinical <sup>18</sup>F-FDG PET/CT were retrospectively enrolled. List-mode PET data acquired at 2 min per bed position were reconstructed using OSEM and DPR, generating the standard-dose images labelled OSEM_full and DPR_full, respectively. To simulate low-dose conditions, the acquisition time of the original list-mode data was reduced to 1/n (n = 2, 3, 4) and reconstructed with DPR, yielding DPR_1/2, DPR_1/3, and DPR_1/4. For all reconstruction groups, quantitative metrics including the standard uptake value (SUV) and coefficient of variation (COV) in the liver, blood pool, and gluteus maximus, as well as lesion tumour-to-background ratio (TBR) and contrast-to-noise ratio (CNR). Subjective image quality was evaluated based on overall image quality, lesion conspicuity, and image noise. Age-stratified subgroup analysis was performed, with OSEM_full as the reference standard.</p><p><strong>Results: </strong>DPR reconstructions showed good agreement in quantitative accuracy with reference imaging. Compared with OSEM_full, DPR_full and DPR_1/2 significantly lowered background COV, DPR_1/3 showed comparable background noise, while DPR_1/4 presented increased noise. All DPR groups yielded significantly higher lesion TBR, and DPR_full, DPR_1/2, DPR_1/3 improved lesion CNR, whereas DPR_1/4 showed reduced CNR. Subjectively, DPR_full and DPR_1/2 achieved significantly higher image quality scores, with over 60% of cases rated as excellent. Age subgroup analysis revealed that DPR_1/3 performance was age-dependent, with better noise control and higher CNR in older children but poorer performance in younger children, suggesting its suitability as an age-adaptive dose reduction strategy. Notably, all DPR protocols improved lesion TBR across all age groups.</p><p><strong>Conclusion: </strong>DPR enables substantial dose reduction in pediatric ¹⁸F-FDG PET while maintaining or even improving objective and subjective image quality. Among the dose-reduction protocols, DPR_1/2 provides the best overall performance, while DPR_1/3 represents the optimal balance between dose reduction and image quality, particularly in older children. These findings support the clinical potential for personalised low-dose PET strategies in the pediatric population.</p>","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149340398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic value of integrated dynamic NLR and [18F]FDG-PET/CT parameters in resectable non-small cell lung cancer treated with neoadjuvant immunotherapy plus chemotherapy. 动态NLR和[18F]FDG-PET/CT综合参数对可切除非小细胞肺癌新辅助免疫治疗加化疗的预后价值。
IF 2.4 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-11-05 DOI: 10.1007/s12149-026-02308-8
Siyun Wang, Fan Yang, Kaiyu Lu, Haoyu Zhu, You Cheng, Dan Shao
{"title":"Prognostic value of integrated dynamic NLR and [<sup>18</sup>F]FDG-PET/CT parameters in resectable non-small cell lung cancer treated with neoadjuvant immunotherapy plus chemotherapy.","authors":"Siyun Wang, Fan Yang, Kaiyu Lu, Haoyu Zhu, You Cheng, Dan Shao","doi":"10.1007/s12149-026-02308-8","DOIUrl":"https://doi.org/10.1007/s12149-026-02308-8","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate the prognostic value of dynamic [<sup>18</sup>F]FDG PET/CT metabolic parameters and the neutrophil-to-lymphocyte ratio (NLR), individually and in combination, in patients with non-small cell lung cancer (NSCLC) receiving neoadjuvant immunotherapy plus chemotherapy.</p><p><strong>Methods: </strong>We retrospectively analyzed 168 NSCLC patients treated with neoadjuvant immunochemotherapy followed by surgery. Pre- and post-treatment PET metabolic parameters assessed by iPERCIST and peripheral blood NLR were collected. Receiver operating characteristic (ROC) analysis and Kaplan-Meier survival analysis with Cox regression were performed to identify predictors of disease-free survival (DFS).</p><p><strong>Results: </strong>During a median follow-up of 25.2 months (95% CI, 21.0-29.3 months), 59 patients experienced recurrence. Post-treatment PET metabolic parameters, their changes, and post-treatment NLR were significantly associated with DFS. Among these parameters, ΔSUVmax and post-treatment NLR were identified as independent prognostic factors. Patients were stratified into three risk groups according to the combination of ΔSUVmax and post-treatment NLR, with significantly different DFS outcomes among groups (p = 0.001). Patients achieving iCMR/iPMR according to iPERCIST criteria showed longer DFS than those without favorable metabolic response (p = 0.005) .</p><p><strong>Conclusions: </strong>Dynamic PET metabolic parameters, and post-treatment NLR hold significant prognostic value following neoadjuvant immunotherapy plus chemotherapy in NSCLC. A combined model integrating PET metabolic parameters and post-treatment NLR stratified patients into distinct risk groups, suggesting potential utility in postoperative risk assessment.</p>","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149340399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of convenient correction methods for collimator-dependent differences in the heart-to-mediastinum ratio from cardiac 123I-MIBG imaging. 验证心脏123I-MIBG成像中准直器依赖性心脏与纵隔比值差异的便捷校正方法。
IF 2.4 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-11-03 DOI: 10.1007/s12149-026-02309-7
Yusuke Inoue, Yutaka Abe, Kohei Mitsui, Hiroki Miyatake, Keita Takahashi, Kei Kikuchi, Eiji Kitamura, Sota Oguro, Kazutoshi Nishiyama
{"title":"Validation of convenient correction methods for collimator-dependent differences in the heart-to-mediastinum ratio from cardiac <sup>123</sup>I-MIBG imaging.","authors":"Yusuke Inoue, Yutaka Abe, Kohei Mitsui, Hiroki Miyatake, Keita Takahashi, Kei Kikuchi, Eiji Kitamura, Sota Oguro, Kazutoshi Nishiyama","doi":"10.1007/s12149-026-02309-7","DOIUrl":"https://doi.org/10.1007/s12149-026-02309-7","url":null,"abstract":"<p><strong>Objective: </strong>High-energy photons emitted by <sup>123</sup>I may penetrate the septa of a collimator, thereby degrading quantitative accuracy. Collimator choice affects the evaluation of the heart-to-mediastinum (H/M) ratio in cardiac sympathetic imaging with <sup>123</sup>I-metaiodobenzylguanidine (<sup>123</sup>I-MIBG). We investigated the validity of previously reported convenient methods for correcting collimator-dependent differences in the H/M ratio.</p><p><strong>Methods: </strong>Twenty patients who underwent cardiac <sup>123</sup>I-MIBG imaging for evaluation of neurodegenerative diseases on a gamma camera system provided by GE Healthcare were studied. Anterior chest images were acquired successively with three collimators: the low-energy high-resolution and sensitivity (LEHRS), extended low-energy general-purpose (ELEGP), and medium-energy general-purpose (MEGP) collimators. The H/M ratios were estimated using various correction methods: <sup>123</sup>I-dual-window (IDW) correction using the high-energy subwindow, empiric correction based on <sup>123</sup>I point-source imaging, combined correction using the high-energy subwindow and point-source imaging, and phantom-based method using imaging of a dedicated phantom. Empiric correction and combined correction had been established using patient data mainly obtained with a system provided by Siemens Healthineers.</p><p><strong>Results: </strong>The uncorrected H/M ratios obtained with the LEHRS collimator correlated closely with those obtained with the MEGP collimator but were substantially smaller, indicating severe underestimation with the LEHRS collimator, attributable to septal penetration. The underestimation remained but decreased after any correction. The H/M ratios after correction were largest with combined correction, followed by empiric correction, phantom-based correction, and IDW correction. The absolute errors after correction were smallest for combined correction, followed by empiric correction, phantom-based correction, and IDW correction. The underestimation was substantially smaller with the ELEGP collimator than with the LEHRS collimator, and any type of correction reduced the underestimation.</p><p><strong>Conclusions: </strong>Convenient correction methods using <sup>123</sup>I point-source imaging were valid for reducing collimator-dependent differences in the H/M ratio in cardiac <sup>123</sup>I-MIBG imaging, demonstrating their applicability to a GE system.</p>","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149317359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A reference-based approach using whole-brain segmentation for estimating blood activity concentration in CBV quantification. 基于参考的全脑分割方法在CBV定量中估计血液活性浓度。
IF 2.4 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-10-24 DOI: 10.1007/s12149-026-02306-w
Nobuyuki Kudomi, Masatoshi Morimoto, Yukito Maeda, Takashi Norikane, Katsuya Mitamura, Yuri Manabe, Mitsumasa Murao, Masaki Tatano, Yuka Yamamoto, Tetsuhiro Hatakeyama, Yoshihiro Nishiyama
{"title":"A reference-based approach using whole-brain segmentation for estimating blood activity concentration in CBV quantification.","authors":"Nobuyuki Kudomi, Masatoshi Morimoto, Yukito Maeda, Takashi Norikane, Katsuya Mitamura, Yuri Manabe, Mitsumasa Murao, Masaki Tatano, Yuka Yamamoto, Tetsuhiro Hatakeyama, Yoshihiro Nishiyama","doi":"10.1007/s12149-026-02306-w","DOIUrl":"https://doi.org/10.1007/s12149-026-02306-w","url":null,"abstract":"<p><strong>Background: </strong>Quantitative imaging of cerebral blood flow (CBF), oxygen extraction fraction (OEF), cerebral metabolic rate of oxygen (CMRO<sub>2</sub>), and cerebral blood volume (CBV) using <sup>15</sup>O-labeled compounds is useful for evaluating cerebral ischemia. However, quantitative PET requires measurement of blood activity concentration, which is typically obtained by arterial blood sampling. Although image-derived and reference-based input function methods have been developed for CBF, OEF, and CMRO<sub>2</sub> quantification, a non-invasive method for obtaining blood activity concentration for CBV measurement has not been established. This study aimed to develop and validate a reference-based method for estimating blood activity concentration from C<sup>15</sup>O PET images.</p><p><strong>Methods: </strong>Among 186 subjects, mean CBV and the coefficient of variation (CV) were calculated for each brain segment in 64 subjects (Group A; moyamoya disease (MMD) present/absent, 20/44). In an independent cohort of 122 subjects (Group B; MMD present/absent, 35/87), blood activity concentration was estimated for each brain segment by reproducing the reference mean CBV obtained from Group A. The segment-based estimates were combined using CV-weighted averaging. The estimated blood activity concentrations were compared with those obtained by arterial blood sampling.</p><p><strong>Results: </strong>The mean ± SD of CBV across all segments in Group A was 0.039 ± 0.011 ml/g overall, 0.037 ± 0.009 ml/g in subjects without MMD, and 0.043 ± 0.012 ml/g in subjects with MMD. In Group B, the percentage differences between reference-based and measured blood activity concentrations were 0.35 ± 9.8%, -1.4 ± 8.8%, and 4.8 ± 10.6% in the overall, MMD-absent, and MMD-present groups, respectively, using the all-segment approach. When the CBV-matched segment approach was applied, the corresponding differences were -0.60 ± 8.8%, -1.4 ± 8.4%, and 1.5 ± 9.4%, respectively.</p><p><strong>Conclusions: </strong>The reference-based blood activity concentrations showed good agreement with those obtained by arterial blood sampling, and the CBV-matched segment approach reduced the difference in the MMD-present group. The proposed method may enable non-invasive and automated estimation of blood activity concentration for quantitative CBV measurement without arterial blood sampling.</p>","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149261111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deep learning-based simultaneous separation of overlapping projection data and attenuation and scatter correction for multi-pinhole SPECT. 基于深度学习的多针孔SPECT重叠投影数据同时分离及衰减散射校正。
IF 2.4 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-10-24 DOI: 10.1007/s12149-026-02307-9
Takumi Akatsuka, Koichi Ogawa
{"title":"Deep learning-based simultaneous separation of overlapping projection data and attenuation and scatter correction for multi-pinhole SPECT.","authors":"Takumi Akatsuka, Koichi Ogawa","doi":"10.1007/s12149-026-02307-9","DOIUrl":"https://doi.org/10.1007/s12149-026-02307-9","url":null,"abstract":"<p><strong>Objective: </strong>Multi-pinhole SPECT offers improved sensitivity and spatial resolution; however, overlapping projection data and multiple sources of physical image degradation remain major challenges. We propose a novel convolutional neural network (CNN)-based framework that simultaneously separates overlapping projections and corrects for gamma-ray attenuation, scatter, quantum noise, and aperture effects without requiring an attenuation coefficient map (μ-map) derived from X-ray CT.</p><p><strong>Methods: </strong>Brain imaging was investigated using a three-detector stationary SPECT system equipped with a 44-pinhole collimator (pinhole diameter, 2 mm). A U-Net++-based CNN was trained to separate overlapping projections and correct multiple physical degradation factors. The input comprised overlapping projection data generated by Monte Carlo photon transport simulations, whereas the target data were ideal projections calculated using a ray-tracing method without projection overlap, attenuation, scatter, or other physical effects. A publicly available brain image dataset comprising 60 cases was used for training (4,050 images), validating (144 images) and testing (126 images). Corrected projections were reconstructed using the maximum-likelihood expectation-maximization (ML-EM) method. Image quality was evaluated visually and quantitatively using the normalized mean squared error (NMSE), peak signal-to-noise ratio (PSNR), structural similarity index measure (SSIM), and regional uptake bias. One-sided t-tests were performed against images reconstructed with 11 non-overlapping pinholes, and a fan-beam collimator method.</p><p><strong>Results: </strong>The proposed framework accurately separated overlapping projections and simultaneously suppressed attenuation, scatter, quantum noise, and aperture-related degradation. It also reduced artifacts caused by the limited number of projections. The proposed method with a quasi-stationary data acquisition achieved an NMSE of 0.18 ± 0.02, a PSNR of 18.42 ± 0.69 dB, and an SSIM of 0.81 ± 0.04, outperforming 11-pinhole reconstruction (NMSE, 0.23 ± 0.05; PSNR, 15.72 ± 1.27 dB; SSIM, 0.78 ± 0.06) and fan-beam reconstruction with a 20-fold longer acquisition time (NMSE, 0.20 ± 0.03; PSNR, 15.93 ± 1.12 dB; SSIM, 0.78 ± 0.05).</p><p><strong>Conclusions: </strong>The proposed CNN-based framework enables simultaneous projection separation and correction of multiple physical degradation factors in stationary multi-pinhole SPECT without CT-derived attenuation correction. This approach may reduce radiation exposure and system cost while enabling high-sensitivity, high-resolution, and quantitatively accurate SPECT imaging.</p>","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149261138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glass versus resin microspheres in ⁹⁰Y radioembolization for hepatocellular carcinoma: toxicity patterns under uniform voxel-based dosimetry. 玻璃微球与树脂微球在肝细胞癌的放射栓塞治疗中的作用:均匀体素剂量下的毒性模式。
IF 2.4 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-10-12 DOI: 10.1007/s12149-026-02300-2
Ali Dablan, Enes Mustafa Kaya, Meryem Kaya, Emrah Birol, Çağrı Erdim, Mustafa Fatih Arslan, Mehmet Cingöz, Oğuzhan Türksayar, Cihan Şin, Halil Burak Kapucu, İpek Kerimel Öztürk, İlker Mahmut Kayaoğlu, Tevfik Güzelbey, Burcu Esen Akkaş
{"title":"Glass versus resin microspheres in ⁹⁰Y radioembolization for hepatocellular carcinoma: toxicity patterns under uniform voxel-based dosimetry.","authors":"Ali Dablan, Enes Mustafa Kaya, Meryem Kaya, Emrah Birol, Çağrı Erdim, Mustafa Fatih Arslan, Mehmet Cingöz, Oğuzhan Türksayar, Cihan Şin, Halil Burak Kapucu, İpek Kerimel Öztürk, İlker Mahmut Kayaoğlu, Tevfik Güzelbey, Burcu Esen Akkaş","doi":"10.1007/s12149-026-02300-2","DOIUrl":"https://doi.org/10.1007/s12149-026-02300-2","url":null,"abstract":"<p><strong>Objectives: </strong>To compare safety outcomes and toxicity patterns of glass and resin microspheres in patients undergoing yttrium-90 (⁹⁰Y) transarterial radioembolization (TARE) for hepatocellular carcinoma (HCC), using uniform voxel-based dosimetry for both platforms and toxicity comparisons adjusted for treatment extent and tumor burden.</p><p><strong>Materials and methods: </strong>This retrospective single-center study included 103 consecutive patients with HCC and preserved liver function treated with ⁹⁰Y-TARE between June 2020 and June 2024 using glass-based (n = 70) or resin-based (n = 33) microspheres, selected according to routine practice and product availability. Absorbed doses for both cohorts were derived from voxel-based ⁹⁹ᵐTc-MAA SPECT/CT dosimetry. Adverse events (AEs) were graded with CTCAE version 5.0. The primary endpoint was overall AE incidence; secondary endpoints were specific toxicity patterns and dose-toxicity associations, examined with multivariable logistic regression adjusting for treatment extent and tumor volume. Progression-free survival (PFS) and overall survival (OS) were compared with the log-rank test.</p><p><strong>Results: </strong>Overall AE incidence did not differ between glass and resin microspheres (glass 37.1% vs. resin 30.3%; p = 0.497), and all AEs were grade 1-2. Tumor and non-tumorous liver absorbed doses were similar. Bilirubin toxicity was more frequent with glass microspheres (glass 28.6% vs. resin 9.1%; p = 0.027), whereas hemoglobin decline was more common with resin microspheres (glass 10.0% vs. resin 30.3%; p = 0.010); both exploratory differences persisted after adjustment for treatment extent and tumor volume. Lung shunt fraction, a baseline patient-level parameter, was higher with resin (glass 2.6% vs. resin 4.1%; p = 0.043). Higher lung absorbed dose was associated with AE occurrence overall, without a significant lung dose × microsphere-type interaction (p = 0.41). Neither PFS (median, glass 9 vs. resin 12 months; p = 0.868) nor OS (glass 23 vs. resin 29 months; p = 0.929) differed significantly.</p><p><strong>Conclusions: </strong>Glass and resin microspheres showed no significant difference in overall AE incidence-without formally establishing equivalence-but differed in their patterns of mild laboratory toxicity independently of treatment extent and tumor burden. These exploratory findings support careful, individualized dosimetric assessment and require confirmation in prospective multicenter studies, but do not provide criteria for microsphere selection.</p>","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149164577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of SUVmax and never-smoker/never- or minimally-drinker history with PD-L1 expression in resected oral squamous cell carcinoma: a nodal-status-stratified analysis. SUVmax和从不吸烟/从不饮酒或极少饮酒史与切除的口腔鳞状细胞癌中PD-L1表达的关联:一项淋巴结状态分层分析
IF 2.4 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-10-12 DOI: 10.1007/s12149-026-02301-1
Yuhua Hu, Ying Yuan, Ting Gu, Feng Xu
{"title":"Association of SUVmax and never-smoker/never- or minimally-drinker history with PD-L1 expression in resected oral squamous cell carcinoma: a nodal-status-stratified analysis.","authors":"Yuhua Hu, Ying Yuan, Ting Gu, Feng Xu","doi":"10.1007/s12149-026-02301-1","DOIUrl":"https://doi.org/10.1007/s12149-026-02301-1","url":null,"abstract":"<p><strong>Background: </strong>Programmed death-ligand 1 (PD-L1) is a critical biomarker for immunotherapy selection in oral squamous cell carcinoma (OSCC). However, the relationships between PD-L1 expression and non-invasive indicators, such as metabolic parameters derived from <sup>18</sup>F-FDG PET/CT and never-smoker/never- or minimally-drinker (NSND) history, remain poorly defined. Moreover, whether these associations differ across nodal subgroups has not been investigated.</p><p><strong>Methods: </strong>This retrospective study included 147 patients with resected OSCC who underwent preoperative PET/CT. Factors associated with high PD-L1 expression (combined positive score [CPS] ≥ 20) were assessed using logistic regression in the overall cohort and with subgroup analyses stratified by nodal status and formal interaction testing.</p><p><strong>Results: </strong>In the overall cohort, maximum standardized uptake value (SUVmax) (odds ratio [OR] per unit increase = 1.067; 95% confidence interval [CI]: 1.013-1.123; P = 0.014) and gender (OR = 2.254; 95% CI: 1.029-4.936; P = 0.042) were independently associated with high PD-L1 expression. After stratification by nodal status, no clinicopathological or metabolic variable was significantly associated with PD-L1 expression in pN0 patients. In contrast, among pN+ patients, SUVmax (OR per unit increase = 1.113; 95% CI: 1.015-1.222; P = 0.024) and NSND (OR = 4.127; 95% CI: 1.362-12.501; P = 0.012) emerged as independent predictors. The NSND × pN interaction was significant (P = 0.004), whereas the SUVmax × pN interaction was not (P = 0.225).</p><p><strong>Conclusions: </strong>SUVmax may serve as a candidate non-invasive indicator, whereas the association between NSND and high PD-L1 expression was modified by nodal status, with a significant effect in node-positive patients. These findings are hypothesis-generating and require external validation.</p>","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149164227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Head-to-head comparison of ⁶⁸Ga-FAPI and ¹⁸F-FDG PET/CT in intracranial space-occupying lesions. 26⁸Ga-FAPI与¹⁸F-FDG PET/CT在颅内占位性病变中的头部比较。
IF 2.4 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-10-12 DOI: 10.1007/s12149-026-02304-y
Raydel BrianKwee Amalo, Aih Cahyani, Hendra Budiawan, Budi Darmawan, Kharisma Perdani Kusumahstuti, Arifudin Achmad, Basuki Hidayat, Achmad Hussein Sundawa Kartamihardja
{"title":"Head-to-head comparison of ⁶⁸Ga-FAPI and ¹⁸F-FDG PET/CT in intracranial space-occupying lesions.","authors":"Raydel BrianKwee Amalo, Aih Cahyani, Hendra Budiawan, Budi Darmawan, Kharisma Perdani Kusumahstuti, Arifudin Achmad, Basuki Hidayat, Achmad Hussein Sundawa Kartamihardja","doi":"10.1007/s12149-026-02304-y","DOIUrl":"https://doi.org/10.1007/s12149-026-02304-y","url":null,"abstract":"<p><strong>Purpose: </strong>Intracranial space-occupying lesions (SOL), including primary brain tumors, metastases, and inflammatory lesions, require accurate characterization for diagnosis and management. Although ¹⁸F-FDG PET/CT reflects tumor glucose metabolism, its performance in the brain is limited by high physiological uptake. ⁶⁸Ga-FAPI PET/CT targets fibroblast activation protein in the tumor microenvironment and may provide complementary biological information with improved lesion conspicuity. This study aimed to compare ⁶⁸Ga-FAPI and ¹⁸F-FDG PET/CT for the evaluation of intracranial SOL.</p><p><strong>Methods: </strong>Thirty-five patients with 55 intracranial lesions underwent paired ⁶⁸Ga-FAPI and ¹⁸F-FDG PET/CT within a 7-day interval. Imaging findings were compared with histopathology (n = 9) and/or MRI (n = 46) as reference standards. Lesion detection rate, diagnostic performance, tumor-to-background ratio (TBR), and semi-quantitative uptake parameters normalized to lean body mass (SUL) were evaluated. Receiver operating characteristic (ROC) analyses were performed to assess the ability of each tracer to differentiate neoplastic from non-neoplastic lesions.</p><p><strong>Results: </strong>⁶⁸Ga-FAPI PET/CT detected more lesions than ¹⁸F-FDG PET/CT (48/55, 87.3% vs. 36/55, 65.5%) and approached the detection rate of MRI (54/55, 98.2%). FAPI demonstrated higher sensitivity and accuracy, whereas FDG showed higher specificity. FAPI demonstrated a significantly higher tumor-to-background ratio (TBR) than FDG (median, 342.00 [IQR, 164.25-502.00] vs. 4.71 [IQR, 3.48-7.42]; Z = 5.07, p < 0.001) in paired analysis of 34 lesions with measurable uptake on both tracers. In primary tumors, FAPI detected all lesions (13/13), whereas FDG detected 9/13 lesions. ROC analysis showed comparable diagnostic performance for differentiating neoplastic from non-neoplastic lesions (AUC 0.794 for FAPI vs. 0.796 for FDG). Exploratory analysis in high-grade tumors (n = 5) suggested a potential association between higher FDG uptake and shorter overall survival.</p><p><strong>Conclusion: </strong>In this cohort, intracranial lesions were predominantly metastatic, with MRI showing the highest detection rate. Compared with ¹⁸F-FDG PET/CT, ⁶⁸Ga-FAPI PET/CT demonstrated higher lesion detection and tumor-to-background contrast, approaching MRI performance. These findings support a complementary role for ⁶⁸Ga-FAPI PET/CT alongside MRI and ¹⁸F-FDG PET/CT in selected intracranial lesions, particularly when lesion conspicuity is limited by the high physiological brain uptake of FDG.</p>","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149164733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书